DENTSPLY SIRONA Inc (NASDAQ:XRAY) Holdings Raised by MAI Capital Management

Share on StockTwits

MAI Capital Management grew its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 27.2% in the second quarter, according to its most recent filing with the SEC. The fund owned 6,159 shares of the medical instruments supplier’s stock after acquiring an additional 1,316 shares during the quarter. MAI Capital Management’s holdings in DENTSPLY SIRONA were worth $270,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. raised its holdings in DENTSPLY SIRONA by 0.7% during the 1st quarter. BlackRock Inc. now owns 14,269,268 shares of the medical instruments supplier’s stock valued at $717,889,000 after buying an additional 99,455 shares during the period. Veritas Asset Management LLP raised its holdings in DENTSPLY SIRONA by 19.9% during the 2nd quarter. Veritas Asset Management LLP now owns 10,092,601 shares of the medical instruments supplier’s stock valued at $441,753,000 after buying an additional 1,674,946 shares during the period. Bank of America Corp DE raised its holdings in DENTSPLY SIRONA by 18.2% during the 2nd quarter. Bank of America Corp DE now owns 3,112,821 shares of the medical instruments supplier’s stock valued at $136,248,000 after buying an additional 479,365 shares during the period. Orbimed Advisors LLC raised its holdings in DENTSPLY SIRONA by 963.8% during the 2nd quarter. Orbimed Advisors LLC now owns 2,393,500 shares of the medical instruments supplier’s stock valued at $104,763,000 after buying an additional 2,168,500 shares during the period. Finally, Champlain Investment Partners LLC raised its holdings in DENTSPLY SIRONA by 23.7% during the 1st quarter. Champlain Investment Partners LLC now owns 2,218,395 shares of the medical instruments supplier’s stock valued at $111,607,000 after buying an additional 424,910 shares during the period. Hedge funds and other institutional investors own 97.62% of the company’s stock.

A number of research firms have weighed in on XRAY. BidaskClub upgraded DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Friday, July 6th. Barclays reduced their target price on DENTSPLY SIRONA from $55.00 to $41.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 8th. Morgan Stanley lowered DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $54.00 to $40.00 in a research note on Wednesday, August 8th. HC Wainwright reiterated a “hold” rating and issued a $40.00 target price on shares of DENTSPLY SIRONA in a research note on Wednesday, August 8th. Finally, Barrington Research lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, August 9th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $52.18.

Shares of DENTSPLY SIRONA stock traded up $0.19 during trading on Friday, hitting $35.87. 2,241,844 shares of the stock traded hands, compared to its average volume of 2,663,035. The firm has a market cap of $8.39 billion, a P/E ratio of 13.48, a P/E/G ratio of 2.18 and a beta of 1.21. The company has a current ratio of 1.69, a quick ratio of 1.10 and a debt-to-equity ratio of 0.31. DENTSPLY SIRONA Inc has a 52-week low of $35.30 and a 52-week high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 EPS for the quarter, beating the consensus estimate of $0.59 by $0.01. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $1.03 billion. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. During the same quarter last year, the firm posted $0.65 earnings per share. Analysts forecast that DENTSPLY SIRONA Inc will post 2.08 earnings per share for the current year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Featured Article: Technical Analysis of Stocks, How Can It Help

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.